Typhoid fever is sometimes a fatal infection to adults and children that causes bacteremia and inflammatory destruction of the intestine and other organs and requires the urgent treatment by the administration of appropriate antibiotics. Recently, fluoroquinolone has proven to be effective for the treatment of typhoid fever, which becomes the first-line drug for the treatment of typhoid fever (3,10,13,17). However, S. enterica serovar Typhi strains resistant to fluoroquinolones and with reduced susceptibility to fluoroquinolones have been already reported (2,6,11,(14)(15)(16). Further, several clinical treatment failures with ciprofloxacin and other fluoroquinolones to typhoid patients infected by the strains with reduced susceptibility to fluoroquinolones have also been reported (12, 16). The emergence and spread of the strains with reduced susceptibility to fluoroquinolones have been reported in several developing countries and also in Japan. The mechanisms of fluoroquinolone resistance have been well studied. Most of the acquired resistant phenotype were attributed to mutations in the genes encoding DNA gyrase (gyrA, gyrB) or DNA topoisomerase IV (parC, parE) (7)(8)(9)(18)(19)(20). The alterations at the codon Ser-83 and Asp-87 of GyrA are the most frequently found in the clinical isolates with reduced susceptibility to fluoroquinolones in S. enterica serovar Typhi and serovar Paratyphi A (1, 5). We previously reported that only gyrA mutations contribute to the fluoroquinolone resistance in S. enterica serovar Typhi and serovar Paratyphi A. Any gyrB, parC and parE mutations which are responsible for the fluoroquinolone resistance were not found in the clinical isolates of S. enterica serovar Typhi and serovar Paratyphi A in our previous study (5). The susceptibility test by diffusion with nalidixic acid disk is now employed for the screen of the strains with reduced susceptibility to fluoroquinolones. However, alternate DNA based method is required for the rapid screening for the strains with reduced susceptibility to fluoroquinolones. The purpose of this study is to develop more rapid screening method for the detection of fluoroquinolone resistant strains and the strain with reduced susceptibility to fluoroquinolones than the ordinary culture method.The bacterial strains used in this study were collected from the regional public health offices in Japan and all isolates were obtained from either a blood culture or a stool culture of individual patients and identified by